ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/dm/volume-2019/1802620/figures/1802620.fig.007a.svgz" name="1802620.fig.007a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>CGGA</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/dm/volume-2019/1802620/figures/1802620.fig.007b.svgz" name="1802620.fig.007b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>TCGA</td></tr><tr class="fig-image" id="c"><td><object data="https://static.hindawi.com/articles/dm/volume-2019/1802620/figures/1802620.fig.007c.svgz" name="1802620.fig.007c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>GSE16011</td></tr><tr class="fig-image" id="d"><td><object data="https://static.hindawi.com/articles/dm/volume-2019/1802620/figures/1802620.fig.007d.svgz" name="1802620.fig.007d" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(d) </b>REMBRANDT</td></tr></table>

<div>ADAMTSL4 predicted worse survival in GBM (WHO grade IV). The overall survival of high- and low-ADAMTSL4 expression in the CGGA (a), TCGA (b), REMBRANDT (c), and GSE16011 (d) databases is quite different.</div>

Disease Markers

fig7

Figure 7

Figure 7: ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme 